日経メディカルのロゴ画像

ISH2006
10月18日 講演概要
← 日付一覧へ ← 10月18日講演一覧へ

10月18日(Wed)

ISH
Sun Palace / Large Hall (Hall A)[8:30-10:00]
  1. Franz Volhard Award and Lectureship
  2. MH Alderman(USA)
    Salt, Blood Pressure, and Cardiovascular Disease(ISH Presidential Lecture)


APSH
Sun Palace / Large Hall (Hall A)[10:00-11:35]
  1. T Ogihara(Japan)
    Molecular Basis of Essential Hypertension(APSH Presidential Lecture)
  2. Yi Zhang(China)
    Department of Cellular and Molecular Biology, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. Shanghai, China
    Positional Identification of Hypertension Susceptibility Gene on 2q14-q23 in Chinese(Abstract No.10299)
  3. Jyh-Ming Juang (Taiwan)
    Devision of Cardiology,Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Dou-Liou city, Taiwan, R.O.C
    Angiotensinogen Gene Haplotype Interacting with Angiotensin Converting Enzyme Gene in Predicting the Development of Left Ventricular Hypertrophy(Abstract No.10122)
  4. Tanya TW Chu(Hong Kong SAR)
    Department of Medicine and Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong, Hong KongSAR, China
    Increased 11 β-Hydroxysteroid Dehydrogenase Type 2 Activity in Hypertensive and Normotensive Siblings in Hong Kong Chinese(Abstract No.11142)
  5. Alexandra Martiniuk(Australia)
    Asia Pacific Cohort Studies Collaboration, The George Institute for International Health, Camperdown, Australia
    Hypertension: its prevalence and population attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region(Abstract No.10482)
  6. Jiguang Wang(China)
    University of Leuven, Leuven, Belgium
    Carotid Intima-Media Thickness and Antihypertensive Treatment: a Meta-analysis of Randomized Controlled Trials(Abstract No.10809)
  7. Rae-Chi Thomson(Australia)
    The University of Western Australia (UWA), School of Medicine and Pharmacology, Royal Perth Hospital
    Inflammation and Altered Liver Function is Present in 13 Year Olds with Features of the Metabolic Syndrome(Abstract No.10245)


OS25HT in Ethnic Subgroups
Fukuoka International Congress Center / Main Hal 3F (Hall E)[10:05-11:40]
  1. Bernard M Y Cheung(Hong Kong SAR)
    The University of Hong Kong
    Prevalence, Awareness, Treatment and Control of Hypertension in the United States 1999-2004(Abstract No.10515)
  2. Roxana Darabont(Romania)
    University Hospital Bucharest
    The Awareness of Hypertension Risk in Romania. Results of S.E.P.H.A.R. - a Population Based Study(Abstract No.11100)
  3. Carla Matos(Mozambique)
    Department of Non Communicable diseases, Ministry of Health, Mozambique
    Prevalence, Awareness, Treatment and Control of Hypertension in Mozambique(Abstract No.11533)
  4. YK Seedat(South Africa)
    Hypertension in Sub-Saharan African Populations: Hypertension in an Unjust World(SOA)
  5. L Liu(China)
    Ethnicity and Hypertension(SOA)


OS26Met-S, DM, Obesity (Basic)
Fukuoka International Congress Center / 201-202 2F (Hall B)[10:10-11:40]
  1. Shinya Taniguchi(Japan)
    Second Department of Internal Medicine, Sapporo Medical University School of Medicine
    Effects of Eplerenone on Insulin Sensitivity in Insulin-Resistant Hypertensive Rats(Abstract No.11342)
  2. Takuo Nambu(Japan)
    Kyoto University Graduate school of Medicine
    Adrenomedullin, a New Adipocytokine Produced and Secreted from Adipose Tissue, Regulated by Adiposity in a Tissue-specific Manner(Abstract No.11059)
  3. Vera Farah(USA)
    Wright State University Boonshoft School of Medicine
    High Fructose Diet Activates Brainstem Angiotensin and Catecholaminergic Systems(Abstract No.11395)
  4. Naoko Iwasa(Japan)
    Division of Cardiovascular and Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, JAPAN
    Attenuation of diet-induced obesity and insulin resistance in mice lacking vascular endothelial cell derived endothelin-1(Abstract No.10459)
  5. Firas Younis(Israel)
    Department of Physiology and Pharmacology, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel
    Effect OF Telmisartan on Hypertension, Hyperglycemia and Humoral Factors in Cohen-Rosenthal Diabetic Hypertensive Rats(Abstract No.10232)
  6. Hiroe Toba(Japan)
    Kyoto Pharmaceutical University
    Spironolactone Exhibits Direct Renoprotective Effects and Inhibits CYP11B2 Expression in the Uninephrectomized Streptozotocin-Induced Diabetic Rat Kidney(Abstract No.10510)


OS27BP Variability, Home BP 1
Fukuoka International Congress Center / 501 5F (Hall H)[10:10-11:40]
  1. Tetsuo Kato(Japan)
    Clinical Pharmacology and Therapeutic, Tohoku University Graduate School of Pharmaceutical Science and Medicine, Sendai, Japan
    Factors Affecting Day-by-Day Variability of Self-Measured Blood Pressure at Home: The Ohasama Study(Abstract No.10612)
  2. Grzegorz Bilo(Poland)
    Dept Clinical Medicine, University of Milano-Bicocca, Milan, Italy
    Weighted 24h Standard Deviation of Systolic Blood Pressure is Related to Carotid Intima Media Thickness Better than Conventional Measures of 24h Blood Pressure Variability. (Abstract No.11546)
  3. Robert H. Fagard(Belgium)
    Hypertension and Cardiovascular Rehabilitation Unit, University of Leuven K.U.Leuven, Leuven, Belgium
    The Value of Daytime and Night-time Blood Pressure for the Prediction of Cause-specific Cardiovascular Events in Hypertension(Abstract No.10138)
  4. Eamon Dolan(Ireland)
    ADAPT Centre, Beaumont Hospital, and Department of Clinical Pharmacology, Royal College of Surgeons in Ireland, Dublin, Ireland.
    PROGNOSTIC SIGNIFICANCE OF THE NOCTURNAL DECLINE IN SYSTOLIC BLOOD PRESSURE: DUBLIN OUTCOME STUDY(Abstract No.11695)
  5. Iddo Z. Ben-Dov (Israel)
    Nephrology and Hypertension, Hadassah-Hebrew University Medical Center Ein-Kerem, Jerusalem, Israel
    Predictors of All Cause Mortality in A Clinical Ambulatory Blood Pressure Monitoring Database: Unique Aaspects of Sleep(Abstract No.11238)
  6. Borislav Georgiev(Bulgaria)
    National Heart Hospital, Sofia, Bulgaria
    Blood Pressure Target Levels in High-Risk Patients(Abstract No.10717)


LCT01Large-scale Clinical Trials 1
Sun Palace / Large Hall (Hall A)[15:10-16:40]
  1. Peter Sever(UK)
    Imperial College London
    Cardiovascular event reduction in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT): Combined benefits of blood pressure reduction, lipid-lowering and treatment with a newer" compared with an "older" antihypertensive treatment regimen"(Abstract No.11649)
  2. Toshio Ogihara(Japan)
    On behalf of CASE-J Study Group
    Clinical Outcomes in Hypertensive Patients with High Cardiovascular Risks: Principal Resutlts of Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Study(Abstract No.11277)
  3. Shawna Nesbitt(USA)
    University of Texas Southwestern Medical Center, Dallas TX, USA
    TROPHY Trial of Preventing Hypertension Underlying Mechanisms(Abstract No.10759)
  4. M Ishii(Japan)
    Yokohama City University
    PRINCIPAL RESULTS OF THE JAPANESE TRIAL TO ASSESS OPTIMAL SYSTOLIC BLOOD PRESSURE IN ELDERLY HYPERTENSIVE PATIENTS(Abstract No.11310)
  5. P Dominiak(Germany)
    for the PHARAO-study-group
    The PHARAO-Study: Prevention of hypertension in patients with high-normal blood pressure with the ACE-inhibitor ramipril - a randomised prevention trial of the German Hypertension League(Abstract No.11720)
  6. Mochizuki Seibu(Japan)
    Japanese Investigation of Kinetic Evaluation In Hypertension Event And Remodeling Treatment Study: JIKEI Heart Study(Abstract No.11742)


LCT02Large-scale Clinical Trials 2
Sun Palace / Large Hall (Hall A)[16:40-18:10]
  1. Hirofumi Makino(Japan)
    Dept Med & Clin Sci, Okayama University Graduate School of Med
    Incipient to Overt: Angiotensin II Blocker, Telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study(Abstract No.10896)
  2. Roland Schmieder(Germany)
    Department of Nephrology and Hypertension, University Erlangen-Nuernberg, Germany
    Reduced Incidence of New Onset Atrial Fibrillation with Angiotensin II Receptor Blockade: The VALUE-Trial(Abstract No.11315)
  3. Tonje A. Aksnes(Norway)
    Department of Cardiology, Ullevaal University Hospital, Oslo, Norway
    Contrasting Impact of New-onset Diabetes Mellitus on Cardiac Morbidity and Mortality in the VALUE Trial Population(Abstract No.10274)
  4. Kashiwagi Atsunori(Japan)
    Microalbuminuria Reduction with the Intensive Antihypertensive Treatment by Renin-Angiotensin System-Blocking or Calcium Channel-Blocking in Hypertensive Patients with Type 2 Diabetes Mellitus(Abstract No.11747)
  5. Yuqing Zhang(China)
    THE FELODIPINE EVENT REDUCTION (FEVER) STUDY: A RANDOMIZED LONG-TERM PLACEBO CONTROLLED TRIAL IN CHINESE HYPERTENSIVE PATIENTS,SUBANALYSIS(Abstract No.11004)
  6. Toshio Kushiro(Japan)
    Nihon University Surugadai Hospital
    Primary prevention of cardiovascular events with pravastatin in patients with hypertension in the MEGA Study: A multi-center randomized controlled trial(Abstract No.10995)
  7. Naritomi Hiroaki(Japan)
    J-HEALTH Study: Japan Hypertension Evaluation with AIIA Losartan Therapy, a Prospective Nationwide Observational Cohort Study(Abstract No.11748)


LBBSLate-Breaking (Basic Session)
Fukuoka International Congress Center / Main Hall 3F (Hall E)[15:10-16:40]
  1. Gozoh Tsujimoto(Japan)
    Kyoto University Graduate School of Pharmaceutical Sciences
    Japan V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity
  2. Dmitry_N Mayorov(Australia)
    Baker Heart Research Institute, Melbourne, Australia
    MICROVASCULAR PERICYTES AS A MAJOR SOURCE OF SUPEROXIDE IN THE ROSTRAL VENTROLATERAL MEDULLA (RVLM): REAL-TIME IMAGING WITH DIHYDROETHIDIUM
  3. Dongqi Xing(USA)
    University of Alabama at Birmingham
    Fcgmma Receptors Enable Human C-reactive Protein to Exacerbate Neointima Formation in Transgenic Mice
  4. David Webb(UK)
    University of Edinburgh
    Cell Type Specific Role for Endothelin B Receptors In The Regulation of BP and Sodium Excretion
  5. Schefe Jan H.(Germany)
    Center for Cardiovacular Research (CCR)/ Institute of Pharmacology and Toxicology, Charite - Universitaetsmedizin Berlin
    A novel signal transduction cascade involving interaction of the renin receptor with the transcription factor PLZF
  6. Josef Zicha(Czech Republic)
    CRC and Institute of Physiology AS CR
    Pertussis Toxin-Sensitive Alpha-Adrenergic Modulation of Voltage-Dependent Calcium Channels in Spontaneously Hypertensive Rats (SHR)


OS28Arterial Stiffness
Fukuoka International Congress Center / Main Hall 3F (Hall E)[16:40-18:10]
  1. Silvia M. Arribas(Spain)
    Facultad de Medicina, Universidad Autonoma de Madrid
    SHR Conduit Vessels Show Elastin Quantitative and Qualitative Abnormalities Before Hypertension Development(Abstract No.11681)
  2. Kazuo Takeda(Japan)
    Kyoto Industrial Health Association
    Late Systolic Blood Pressure Associates More Closely with Carotid Intima-Media Thickness than Systolic Blood Pressure(Abstract No.10528)
  3. Chang C Park(Korea (S))
    Korea University Guro Hospital
    Aortic Stiffness Is a Major Determinant of Proximal Aortic Dilatation in the Hypertensive Patients(Abstract No.11318)
  4. Tine W. Hansen(Denmark)
    Research Center for Prevention and Health, Copenhagen, Denmark
    Ambulatory Arterial Stiffness Index Predicts Stroke in a General Population(Abstract No.10360)
  5. GM London(France)
    Large Artery Damage in Hypertension(SOA)


OS29HT in Developing Countries
Fukuoka International Congress Center / 201-202 2F (Hall B)[16:30-18:10]
  1. S Mendis(Switzerland)
    Challenges for Hypertension Control in Developing Countries(SOA)
  2. S Reddy(India)
    Hypertension in Developing Countries(SOA)
  3. Julio Chirinos(USA)
    Santa Maria Catholic University School of Medicine, Santa Maria Research Institute and PREVENCION Study Group. Arequipa, Peru
    PREVALENCE AND PATTERNS OF HYPERTENSION IN PERUVIAN ANDEAN MESTIZOS: THE PREVENCION STUDY(Abstract No.10236)
  4. Dede Kusmana(Indonesia)
    University of Indonesia/National Cardiovascular Center Harapan Kita
    The impact of lifestyle intervention on the profile of cardiovascular risk factors in urban population of Jakarta, Indonesia(Abstract No.11187)
  5. Masashi Yamori(Tanzania)
    Department of Mexillofacial Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan
    Hypertension and Oral Health: a Possible Nutritional Link in Tanzania(Abstract No.11589)
  6. ANDRE PASCAL KENGNE(Cameroon)
    THE GEORGE INSTITUTE FOR INTERNATIONAL HEALTH
    TEMPORAL CHANGES IN BLOOD PRESSURE LEVELS AND PREVALENCE OF HYPERTENSION IN URBAN AND RURAL CAMEROON: A TEN YEARS TREND STUDY(Abstract No.11570)
  7. Sanjib Kumar Sharma(Nepal)
    B P Koirala Institute of Health Sciences
    High Prevalence of Hypertension and Cardiovascular Risk Score in a Community Based Screening in Dharan (Nepal)(Abstract No.11075)


OS30Kidney and HT 2
Fukuoka International Congress Center / 501 5F (Hall H)[16:40-18:10]
  1. Shigeru Shibata(Japan)
    Department of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan
    Aldosterone induces podocyte injury throgh oxidative stress(Abstract No.10446)
  2. Hirohito Metoki(Japan)
    Tohoku Univirsity Graduate School of Medicine
    Combination of Decreased Kidney Function and pre-Hypertension Affect Mortality Risk in a General Japanese Population: The Ohasama Study(Abstract No.11409)
  3. Albert Mimran(France)
    Department of Internal Medicine, Hopital Lapeyronie, Montpellier, France
    Determinants of discrepancies in the diagnosis of microalbuminuria.(Abstract No.11319)
  4. Olle Melander(Sweden)
    Department of Clinical Sciences, Lund University, Malmoe, Sweden
    MICROALBUMINURIA IS AN INDEPENDENT PREDICTOR OF CARDIOVASCULAR EVENTS IN SWEDISH PATIENTS WITH HYPERTENSION-A SUBSTUDY OF THE NORDIC DILTIAZEM STUDY (NORDIL)(Abstract No.10782)
  5. Ramiro Sanchez(Argentina)
    FUNDAPRES, Buenos Aires, Argentina
    IMPAIRED ATRIAL NATRIURETIC PEPTIDE (ANP) AND PROSTACICLIN (PgI2) ACTIVITY AFFECTS Na+ HOMEOSTASIS IN NON-MODULATING SALT SENSITIVE HYPERTENSION(Abstract No.10033)
  6. Noboru Fukuda(Japan)
    Advanced Research Institute of the Science and Humanities/Nihon University
    Implantation of Dedifferentiated Fat Cells (DFAT) as a Regenative Medicine for Progressive Renal Diseases(Abstract No.10326)


← 日付一覧へ ← 10月18日講演一覧へ